The University of Texas M.D. Anderson Cancer Center is progressive in their research and mesothelioma treatment initiatives.
The Mesothelioma Cancer Department has a comprehensive program with over 30 specialists on staff dedicated and focused on mesothelioma. In their approach for mesothelioma treatment, the specialist team determines the patient’s cancer stage and if they are a candidate for surgery.
In conjunction with the surgical staging, Anderson is conducting a clinical trial of the drug, Dasatinib. Prior to surgery, patients are given Dasatinib to test the effectiveness of the drug therapy in preventing the progression of the disease.
For more information about mesothelioma treatment, check out the M.D. Anderson web site, or visit our pages on clinical trials, cancer centers, and leading mesothelioma doctors.
